These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17223505)

  • 1. The future treatment of portal hypertension.
    Reichen J; Lebrec D
    Best Pract Res Clin Gastroenterol; 2007; 21(1):191-202. PubMed ID: 17223505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal hypertension: state of the art.
    Gatta A; Sacerdoti D; Bolognesi M; Merkel C
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):326-45. PubMed ID: 10425579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide.
    Rockey D
    Hepatology; 1997 Jan; 25(1):2-5. PubMed ID: 8985256
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vasoactive mediators in portal hypertension.
    García-Pagán JC; Bosch J; Rodés J
    Semin Gastrointest Dis; 1995 Jul; 6(3):140-7. PubMed ID: 7551971
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
    Hennenberg M; Trebicka J; Buecher D; Heller J; Sauerbruch T
    Liver Int; 2009 Jul; 29(6):933-41. PubMed ID: 19490424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Portal hypertension].
    Sieber CC
    Ther Umsch; 1997 Nov; 54(11):635-8. PubMed ID: 9454365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Portal hypertension and angiogenesis].
    Stumm M; Sieber C
    Schweiz Med Wochenschr; 2000 Feb; 130(7):233-9. PubMed ID: 10719714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
    Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?
    Rasaratnam B; Connelly N; Chin-Dusting J
    Clin Sci (Lond); 2004 Nov; 107(5):425-34. PubMed ID: 15270715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal hypertension and the hyperdynamic circulation: nitric oxide in a haze of cannabinoid smoke.
    Shah V
    Hepatology; 2001 Nov; 34(5):1060-1. PubMed ID: 11679979
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
    Shah V
    J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.
    Iwakiri Y; Groszmann RJ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S121-31. PubMed ID: 16447289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.